1 / 7

Hisao Ogawa et al. JAMA 2008;300:2134-2141

Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial. Hisao Ogawa et al. JAMA 2008;300:2134-2141. Baseline Clinical Characteristics – Part I. Hisao Ogawa et al. JAMA 2008;300:2134-2141. Baseline Clinical Characteristics – Part II.

sheena
Download Presentation

Hisao Ogawa et al. JAMA 2008;300:2134-2141

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:2134-2141

  2. Baseline Clinical Characteristics – Part I Hisao Ogawa et al. JAMA 2008;300:2134-2141

  3. Baseline Clinical Characteristics – Part II Hisao Ogawa et al. JAMA 2008;300:2134-2141

  4. Atherosclerotic Events Hisao Ogawa et al. JAMA 2008;300:2134-2141

  5. Total Percentage of Atherosclerotic Events According to Treatment Group Hisao Ogawa et al. JAMA 2008;300:2134-2141

  6. Subgroup Analysis of Incidence of Atherosclerotic Events Hisao Ogawa et al. JAMA 2008;300:2134-2141

  7. Adverse Effects Hisao Ogawa et al. JAMA 2008;300:2134-2141

More Related